CHAWAI COMMUNITY APPEALS TO GOV. UBA SANI FOR RELIEF, MEDICAL SUPPORT AFTER DEADLY KAURU ATTACK. (PHOTO).

Image
 Chawai Community Appeals To Gov. Uba Sani For Relief, Medical Support After Deadly Kauru Attack The people of Chawai Chiefdom in Kauru Local Government Area of Kaduna State have appealed to Governor Uba Sani to provide urgent relief and medical assistance to victims of the deadly attack on Naridon village in Kamaru Ward. In an open letter addressed to the governor, the community commended his leadership, describing his administration as inclusive and fair. They said this had given residents confidence that every community in the state is valued. The community, however, expressed concern over what it described as the lack of government intervention following the attack on Naridon village, in which it said 30 people were killed. According to the letter, many survivors and families of the victims are still struggling with grief, trauma, displacement, and the challenges of caring for those injured in the attack. The community said many affected residents feel neglected, as they have y...

CHINESE COVID-19 VACCINE SHOWS PROMISING RESULTS.[PHOTO}.

Chinese COVID-19 vaccine shows promising results - CGTN
   We are all expecting a COVID-19 vaccine that could possibly end the pandemic that has killed more than 330,000 people.
Now the first vaccine candidate from China has finished its phase-1 trial on humans, and the results have been put online for everyone to examine.
The Lancet, a respected medical journal in the UK, published the results on Friday saying it is "safe" and "induces rapid immune response."
The research injected the potential vaccine into 108 volunteers.
They were divided into three groups, each taking a different dose of the vaccine.
The vaccine, classified as "recombinant adenovirus type-5 vectored" (Ad5-nCoV), acts as a natural infection and is especially good at teaching the immune system how to fight the virus.During the next 28 days, no serious reactions were found, meaning the vaccine seemed to be tolerable by humans.Also, antibodies against the SARS-CoV-2 started to surge two weeks after the injection and reached its peak on day 28.The vaccine "warrants further investigation," the paper on The Lancet concluded.A phase-2 clinical trial has started with 508 volunteers involved.The trial was conducted by a team led by Chen Wei, a biology professor from Academy of Military Medical Sciences and a member of the Chinese Academy of Engineering.There are other two vaccines allowed for human trials in China. They are ShaCoVacc and PiCoVacc.-CCTV.
Chinese COVID-19 vaccine shows promising results - CGTN

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

MUSICIAN HARRY-SONG,REVEALS THE FACE OF THE FEMALE FAN WHO IS THREATENING TO KILL HIM.{PHOTOS}.

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.